Detalles de la búsqueda
1.
Assembly of a GPCR-G Protein Complex.
Cell
; 177(5): 1232-1242.e11, 2019 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31080064
2.
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
N Engl J Med
; 389(12): 1069-1084, 2023 Sep 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37622681
3.
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions.
N Engl J Med
; 389(16): 1477-1487, 2023 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37634149
4.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial.
Circulation
; 149(3): 204-216, 2024 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952180
5.
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Lancet
; 403(10437): 1635-1648, 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599221
6.
Semaglutide and Diuretic Use in Obesity-Related Heart Failure with Preserved Ejection Fraction: A Pooled Analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.
Eur Heart J
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739118
7.
Wireless continuous single-lead ST-segment monitoring to detect new-onset myocardial injury at the general ward-An exploratory subanalysis.
Acta Anaesthesiol Scand
; 68(5): 681-692, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425057
8.
Asthma and exercise-induced bronchoconstriction in athletes: Diagnosis, treatment, and anti-doping challenges.
Scand J Med Sci Sports
; 34(1): e14358, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965010
9.
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.
Circulation
; 145(8): 575-585, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34903039
10.
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo.
Kidney Int
; 103(4): 772-781, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738891
11.
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
Cardiovasc Diabetol
; 22(1): 220, 2023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620807
12.
Continuous wireless pre- and postoperative vital sign monitoring reveal new, severe desaturations after vascular surgery.
Acta Anaesthesiol Scand
; 67(1): 19-28, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267029
13.
Continuous monitoring is superior to manual measurements in detecting vital sign deviations in patients with COVID-19.
Acta Anaesthesiol Scand
; 67(5): 640-648, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852515
14.
Wireless Single-Lead versus Standard 12-Lead ECG, for ST-Segment Deviation during Adenosine Cardiac Stress Scintigraphy.
Sensors (Basel)
; 23(6)2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36991673
15.
Deviations in continuously monitored electrodermal activity before severe clinical complications: a clinical prospective observational explorative cohort study.
J Clin Monit Comput
; 37(6): 1573-1584, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37195623
16.
Quantifying physiological stability in the general ward using continuous vital signs monitoring: the circadian kernel density estimator.
J Clin Monit Comput
; 37(6): 1607-1617, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37266711
17.
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6.
Stroke
; 53(9): 2749-2757, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582947
18.
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials.
Cardiovasc Diabetol
; 21(1): 172, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36056351
19.
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6.
Cardiovasc Diabetol
; 21(1): 64, 2022 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35484580
20.
The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials.
Diabetes Obes Metab
; 24(2): 281-288, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676658